Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma

	Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma
刊名	CHINESE JOURNAL OF CANCER
	2016
卷号	35
关键词	CONCURRENT CHEMORADIOTHERAPY PROGNOSTIC-FACTORS RADIATION-THERAPY NECK-CANCER REIRRADIATION CHEMOTHERAPY SURVIVAL METAANALYSIS RETREATMENT HEAD Recurrence Nasopharyngeal carcinoma Intensity-modulated radiation therapy Concomitant chemoradiotherapy Cisplatin
ISSN号	1000-467X
其他题名	Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma
英文摘要	Background: Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC) is complicated and relatively limited. Radiotherapy, combined with effective concomitant chemotherapy, may improve clinical treatment outcomes. We conducted a phase II randomized controlled trial to evaluate the efficacy of intensity-modulated radiotherapy with concomitant weekly cisplatin on locally recurrent NPC.
语种	英语
CSCD记录号	CSCD:5690104
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/61847]
专题	中国科学院合肥物质科学研究院
推荐引用方式 GB/T 7714	. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma[J]. CHINESE JOURNAL OF CANCER,2016,35.
APA	(2016).Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma.CHINESE JOURNAL OF CANCER,35.
MLA	"Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma".CHINESE JOURNAL OF CANCER 35(2016).